Do Derivative Accounting Rules Make Sense?

Follow us on LinkedIn

As a firm with emphasis on risk management, we always advise our clients to hedge their portfolios in order to reduce the PnL volatilities.

However, recently Metlife, the largest insurer in the US, was hit by a $3.2 billion loss in derivatives that were used to hedge the rising interest rates, causing a $2.1 billion loss for the quarter overall.

The loss thus brought up an issue: hedging to reduce the revenue volatility works only if the hedging and hedged instruments are at the same level of liquidity and the same accounting rule applies.

Leslie Scism pointed out that the problem is due to the marking to market of the derivative book under GAAP

In the long term, the rise in interest rates bodes well for MetLife. Few American industries are as hurt by low rates as life insurers, which invest huge sums of premium until the money is needed to pay claims. The money is typically invested in higher-quality bonds, so insurers’ profits have been pressured as they put new money to work at the ultralow levels in place since 2008.

MetLife’s results took a hit in the latest period because life insurers must mark their derivatives to market under generally accepted accounting principles. When rates rise, the value of the protection they buy to protect results from low rates falls. Read more

By contrast, Metlife’s liabilities appeared less volatile because the insurer used different assumptions and accounting rules to value their liabilities.

In short, when interest rates rose, the insurer suffered a marked-to-market loss in their derivative hedging book, while the gain in the liability part is not recognized immediately.

The values of both the hedging and hedged assets must be accounted for, but requiring companies to apply different accounting rules to hedging and hedged instruments is too punitive. This can discourage the risk managers to prudently hedge in order to reduce the revenue volatilities.

Maybe a change in accounting rules is needed?

Further questions

What's your question? Ask it in the discussion forum

Have an answer to the questions below? Post it here or in the forum

LATEST NEWSCarlyle group entities sell over $24 million in QuidelOrtho shares
Carlyle group entities sell over $24 million in QuidelOrtho shares
Stay up-to-date with the latest news - click here
LATEST NEWSProtagonist therapeutics director sells $320,000 in stock
Protagonist therapeutics director sells $320,000 in stock
Stay up-to-date with the latest news - click here
LATEST NEWSPineapple financial director buys $21.2k in company shares
Pineapple financial director buys $21.2k in company shares
Stay up-to-date with the latest news - click here
LATEST NEWSEarnings call: Hilltop Holdings reports stable Q2 earnings amid rate challenges
Earnings call: Hilltop Holdings reports stable Q2 earnings amid rate challenges
Stay up-to-date with the latest news - click here
LATEST NEWSEarnings call: Booz Allen reports growth and record backlog in Q1 FY2025
Earnings call: Booz Allen reports growth and record backlog in Q1 FY2025
Stay up-to-date with the latest news - click here

Leave a Reply